|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VASCULAR BIOLOGY
1Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill; and 2National Health and Environmental Effects Research Laboratory, Office of Research and Development, Environmental Protection Agency, Research Triangle Park, North Carolina
Submitted 20 July 2005 ; accepted in final form 24 March 2006
| ABSTRACT |
|---|
|
|
|---|
-methyl-L-argnine, indomethacin, allopurinol, cimetidine, rotenone, and antimycin, had no effects. DPI but not NaN3 attenuated UP-induced pulmonary vasoconstriction and phosphorylation of ERK1/2 and p38 MAPKs. Knockdown of p47phox gene expression by small interfering RNA attenuated UP-induced H2O2 production and phosphorylation of ERK1/2 and p38 MAPKs. Intravascular administration of H2O2 generated by glucose oxidase increased pulmonary artery pressure. We conclude that UP induce oxidative stress in vascular endothelial cells by activating NAD(P)H oxidase and the mitochondria. The endothelial oxidative stress may be an important mechanism for PM-induced acute cardiovascular health effects. mitogen-activated protein kinase; extracellular signal-regulated kinase; p38; vasoconstriction
Recent in vivo and in vitro evidence indicates that PM may also cause endothelial dysfunction and vasoconstriction. Exposure to concentrated ambient particles (CAPs) (median, 182.75 µg/m3) for 5 h/day for 3 days decreased the lumen/wall area ratio of small pulmonary arteries (PA) in rats indicating increased pulmonary vascular resistance (4). PM from motorcycle exhaust enhanced constriction of rat aortic rings induced by phenylephrine (45). Exposure to PM for 4 wk increased atherosclerotic plaque formation in rabbits (42). Co-exposure to CAPs (
150 µg/m3) and ozone (120 ppb) for 2 h causes acute constriction of brachial artery in healthy human adults (9). An air pollution episode in Germany was associated with increases in systemic blood pressure by as much as 8 mmHg (26). Various vasoconstrictor mechanisms are affected by PM, including the release of endothelins (8, 44), activation of the epithelial growth factor receptor (25), and inhibition of nitric oxide (NO) production (2, 8, 25, 27). More recently, we demonstrated that PM caused pulmonary vasoconstriction and activated mitogen-activated protein kinase (MAPK) via activation of angiotensin II receptor subtype 1 (AT1R) (32).
PM also is known to produce oxidative stress in lung cells (17). Chapel Hill particles increased the production of reactive oxygen species (ROS) in human alveolar macrophages and bronchial epithelial cells (6). Diesel particles induced oxidative stress in macrophages (23). PM-induced secretion of amphiregulin was blocked by the antioxidant N-acetylcysteine (7). Ottawa ambient particles (EHC-93) induced blood oxidative stress markers in rats (46). The oxidative stress in these lung cells have been linked mostly to PM-induced pulmonary inflammation. Because the cardiovascular adverse effects induced by PM may occur without lung inflammation, we reasoned that PM may induce oxidative stress directly in vascular endothelial cells. The induction of endothelial oxidative stress is an important mechanism linking many known cardiovascular risk factors, including hyperglycemia, dyslipidemia, hypertension, and cigarette smoking (11), with the development of vascular diseases. To test this hypothesis, we exposed PA endothelial cells to PM and measured extracellular H2O2 production. Our goals were to determine the enzymatic sources of ROS production in vascular endothelial cells and to investigate the effects of ROS from different sources on MAPK activation and vasoconstriction, two cellular events known to occur with PM exposure (32). The study was performed in human PA endothelial cells (HPAECs), isolated PA ring, and isolated buffer-perfused lungs.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-methyl-L-arginine (L-NAME) were obtained from Sigma (St. Louis, MO). Monoclonal antibodies against phospho-p38, total p38, phospho-ERK1/2, and total ERK1/2 were purchased from Cell Signaling Technology (Beverly, MA). Horseradish peroxidase (HRP)-conjugated goat anti-rabbit and goat anti-mouse IgG were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Molecular mass standards, polyacrylamide, and buffers were from Bio-Rad (Richmond, CA). The ECL Western blot analysis detection reagents were purchased from Amersham Biosciences (Piscataway, NJ). Source of particles. Urban particles (SRM 1648) were purchased from the National Institute of Standards and Technology (Gaithersburg, MD). They were prepared from urban PM collected in the St. Louis, MO, area in a baghouse over a period of >12 mo. The material was removed from the filter bags, combined in a single lot, screened through a fine mesh sieve to remove extraneous materials and thoroughly blended in a v-blender. The material was then packaged into sequentially numbered bottles. The major constituent elements are (mass fraction in %) the following: 3.4% Al, 3.9% Fe, 1.1% K+, and the minor constituent elements are 0.43% Na, 0.66% Pb, and 0.48% Zn. There are also metal constituents (in ng/mg), including 115 As, 76 Cd, 403 Cr, 609 Cu, 786 Mn, 82 Ni, 27 Se, 5.5 U, and 127 V. UP was suspended in distilled deionized water for the use in experiments.
Isolated rat PA ring model.
Segments of the right and left main PAs of Sprague-Dawley rats (250350 g) measuring
23 mm were removed and placed in the Krebs-Henseleit buffer, as described previously (31). The artery segments were then suspended in the Radnoti 4-unit tissue organ bath system (Glass Technology, Monrovia, CA). The reservoirs held 20 ml of Krebs-Henseleit buffer and were bubbled constantly with 21% O2 + 5% CO2 gas. After a 10- to 15-min stabilization period, the baseline tension of the rings was adjusted to 1 g before all experiments. The artery rings were then exposed to increasing doses of particles from 1 to 100 µg/ml. Inhibitors were given 15 min before particle exposure. The rings were washed with buffer between the two doses of particles. The maximum tension within 5 min after each dose of particles was recorded.
Cultured HPAECs. HPAECs were grown in EGM-2 supplemented with 2% fetal bovine serum, 0.04% hydrocortisone, 0.4% human fibroblast growth factor-B, 0.1% vascular endothelial growth factor, 0.1% R3-insulin growth factor-1, 0.1% ascorbic acid, 0.1% human epithelial growth factor, 0.1% GA-1000, and 0.1% heparin. Cells at passages 49 grown to 80% confluence were used for the experiments.
Isolated perfused rabbit lung.
The isolated buffer-perfused lung model using male New Zealand White rabbits (May's Farm, Wilson, NC) weighing 2.53.0 kg has been described previously (25). Briefly, the PA and left atrium were cannulated for monitoring mean PA pressure and left atrial pressure, respectively. The left atrial cannula was connected by Tygon tubing to a reservoir suspended freely from a force displacement transducer (model FT100, Grass Instrument, Quincy, MA) for monitoring weight gain of the lung. The reservoir was placed at the lowest portion of the lung to maintain a left atrial pressure of zero. Tubing connecting the reservoir with the main PA cannula completed the perfusion circuit. The perfusion circuit also consisted of a roller pump (Sarns, Ann Arbor, MI), a bubble trap, and a heat exchanger. The volume of the system was
250 ml. Trachea was also cannulated for monitoring tracheal pressure. The lung was ventilated with 21% O2 + 5% CO2 through the tracheostomy using an animal respirator (Harvard Apparatus, S. Natick, MA) delivering 30 breaths per min at 23 cmH2O positive end-expiratory pressure. The tidal volume was adjusted to achieve a peak tracheal pressure of 710 mmHg (
20 ml). All pressures and weight gain were transmitted to a four-channel analog-to-digital converter and amplifier connected to a personal computer equipped with data-acquisition software (DATAQ Instruments, Akron, OH). The Krebs-Henseleit-3% albumin buffer contains 82.8 mM NaCl, 4.7 mM KCl, 2.4 mM monobasic potassium phosphate, 25 mM sodium bicarbonate, 1.2 mM magnesium sulfate, 2.7 mM CaCl, 11.1 mM dextrose, and 3% wt/vol bovine serum albumin, fraction V, at a pH of 7.37.4. After the pulmonary circulation was washed free of blood with the buffer, a recirculating perfused lung system with a flow of 100 ml/min was established. The lung was then allowed 1015 min for stabilization. Lungs with visible leaks and/or high PA pressure (>20 mmHg) during this period were excluded.
Western blot analysis. After exposure, the cells were washed once with ice cold phosphate-buffered saline (PBS) and then lysed with RIPA buffer (1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS in PBS, pH 7.4) containing 0.1 mM vanadyl sulfate and protease inhibitors (0.5 mg/ml aprotinin, 0.5 mg/ml E-64, 0.5 mg/ml pepstatin, 0.5 mg/ml bestatin, 10 mg/ml chymostatin, and 0.1 ng/ml leupeptin). The cell lysates were then centrifuged at 3,000 g for 10 min at 4°C. Protein concentration of supernatant was measured with Bio-Rad protein assay reagent. Cellular proteins were separated by 10% SDS-PAGE and transferred to a polyvinylidene difluoride membrane. The blot was blocked with 5% milk in PBS with 0.05% Tween 20 for 1 h at room temperature, washed briefly, and then probed with goat antibodies against human phospho-p38 or phospho-ERK1/2 overnight at 4°C. This was followed by incubation with HRP-conjugated secondary antibodies. Bands were detected with the use of ECL and films. The blot was then stripped and reprobed with monoclonal antibodies against human p38 or ERK1/2 and appropriate HRP-conjugated secondary antibodies.
Measurements of H2O2. Cells were cultured in 24-well plates. Production of extracellular H2O2 was measured by the Amplex red reagent (10-acetyl-3,7-dihydroxyphenoxazine; Molecular Probes-Invitrogen, Carlsbad, CA). Amplex red reacts with H2O2 to produce highly fluorescent resorufin in the presence of HRP. The fluorescent signals were measured over 120 min with a Bioassay HTS7000 plate reader (Perkin Elmer, Wellesley, MA) with HTSoft version 1.0 software (PE Applied Biosystems, Weiterstadt, Germany). The excitation and emission wavelengths were 530 and 590 nm, respectively. Generation of H2O2 was calculated by subtracting the fluorescence signal at 0 min (baseline) from that at 120 min. Positive controls using H2O2 (0.52 µM) were included for all Amplex red assays. All inhibitors were added 20 min before Amplex red.
Transfection of HPAEC with p47phox siRNA.
Cells were grown to
6070% confluency in 6-well plates. They were then transfected with Gene Silencer transfecting agent plus (Gene Therapy System, San Diego, CA) with p47phox siRNA (100 nM; Dharmacon, Chicago, IL) in serum-free EGM-2 medium for 3 h according to the manufacturer's recommendation. Control cells were incubated with Gene Silencer without p47phox siRNA. Fresh EGM-2 medium with 2% fetal bovine serum was then added, and cells were cultured for an additional 48 h. Cell lysates from some wells were collected for p47phox protein expression and phospho-ERK1/2 and phospho-p38 MAPKs by Western blot analysis. Other wells were used for measuring H2O2 production.
Statistical analysis. Data shown in text and figures are means ± SE. Data from the artery ring experiments and perfused rabbit lungs were analyzed by the repeated-measures ANOVA. Data from the cell experiments were analyzed by ANOVA, followed by Scheffé's test for post hoc comparisons. The statistical analysis was performed using commercially available software (Statview version 5.0.1, SAS Institute, Cary, NC). A P value of <0.05 was taken as statistically significant.
| RESULTS |
|---|
|
|
|---|
|
|
60% that by the whole particles. Because Cu and V are two abundant redox-active metals in the water-soluble fraction of UP, we further tested the effects of these two metals on H2O2 release. As shown in Fig. 3, A and B, copper sulfate (CuSO4) increased H2O2 release in a time- and dose-dependent manner. The Cu-stimulated release of H2O2 was inhibited by DPI, apocynin and NaN3 (Fig. 3, CE). Vanadyl sulfate (VOSO4) also increased H2O2 release in a time- and dose-dependent manner (Fig. 4, A and B). The V-stimulated release of H2O2 was inhibited by NaN3 but not by DPI or apocynin (Fig. 4, CE).
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
H2O2 released by the UP-stimulated endothelial cells comes from two major enzymatic sources, the NAD(P)H oxidase and the mitochondrial electron transport chain, because the release of H2O2 was inhibited by two structurally distinct NAD(P)H oxidase inhibitors (DPI and apocynin), p47phox siRNA and a mitochondrial complex IV inhibitor (NaN3). Other enzyme systems that are potential sources for H2O2, including xanthine oxidase, cytochrome P-450, NO synthase, and cyclooxygenase-1, were less likely sources because their respective inhibitors, (allupurinol, cimetidine, L-NAME, and indomethacin) did not inhibit UP-induced H2O2 release. The NAD(P)H oxidase activity in vascular endothelial cells can be stimulated by many plasma membrane-mediated events, including cytokines, hormones, growth factors, G protein receptor agonists, and shear forces, and activation of NAD(P)H oxidase is known to be involved in the pathogenesis of vascular disease (15, 20, 21, 24, 34). Electron leaks from the mitochondrial electron transport chain of vascular endothelial cells, on the other hand, have been observed with different stimuli, such as hypoxia-reoxygenation and glucocorticoid excess (28, 43). Our results show that UP is a common stimulus for both systems because inhibitors for each system almost completely inhibit the UP-stimulated production of H2O2. It is not possible, however, to assess the relative contribution of each system in part because of the nonspecific effects of these inhibitors. Because DPI and apocynin inhibit UP-induced H2O2 production earlier than NaN3, UP may activate NAD(P)H oxidase first. This hypothesis would be consistent with the cell membrane localization of NAD(P)H oxidase that makes it more accessible to extracellularly administered UP.
The exact components of UP responsible for activating NAD(P)H oxidase and the mitochondrial electron transport chain are not clear. The water-soluble fraction of UP was sufficient to stimulate the release of H2O2. Its transition metals, Cu and V, also enhanced H2O2 release. The patterns of inhibition by DPI, apocynin, and NaN3 on Cu- and V-induced H2O2 production were similar to those on UP-induced H2O2 production. These results indicate that some components in the water-soluble fraction are responsible for changes induced by UP. Whether Cu and V are among the active components will require further studies in the future.
H2O2 produced by NAD(P)H oxidase contributed to PM-induced vasoconstriction because DPI inhibited UP-induced constriction of PA ring and intravascular administration of extracellular H2O2 produced by glucose and glucose oxidase produced acute vasoconstriction in perfused lungs. We and others have previously identified several signaling pathways that mediate PM-induced vasoconstriction, including epidermal growth factor receptor, angiotensin II receptor subtype 1, endothelins, and NO (8, 25, 27, 31, 32, 44). Our results indicate that H2O2 produced by the membrane NAD(P)H oxidase should also be added to the list. The cell membrane localization of NAD(P)H oxidase would allow H2O2 produced by this enzyme to be released directly into the extracellular space and exert its effects on the adjacent smooth muscle cells. The mitochondrial source of H2O2, on the other hand, appears not involved in regulating vascular reactivity because inhibition of H2O2 production by NaN3 did not affect UP-induced vasoconstriction despite increases in ERK1/2 and p38 MAPK phosphorylation. We speculate that a subfamily of mitochondrial MAPKs may be affected by NaN3 (1, 3). These mitochondrial MAPKs show a different response to ROS than the cytosolic MAPKs because H2O2 inhibits rather than increases phosphorylation of mitochondrial ERK1/2 (1). The primary function of the mitochondrial MAPKs appears different from that of the cytosolic MAPKs. Activation of the mitochondrial p38 MAPK mediates ceramide-induced apoptosis (30). Activation of mitochondrial ERK MAPK induces phosphorylation of a pro-apoptotic protein Bad preventing cell death in murine heart (3). Activation of the mitochondrial MAPKs subfamily and the specific role of mitochondrial MAPKs in cell death signaling may explain why NaN3 did not affect UP-induced vasoconstriction despite an increase in phosphorylated ERK1/2 and p38 MAPKs. More studies in the future will be needed to test this hypothesis.
Extrapolation of our in vitro results to human exposure to ambient PM should be made with caution. The doses of UP to which endothelial cells were exposed were much higher than the one-time exposure in most ambient settings. With repeated exposures during severe pollution episodes (38, 40) and under certain occupational conditions (22, 47), the amount of PM inhaled into the lung may increase several hundred fold. Although the whole inhaled particles are unlikely in direct contact with vascular endothelial cells, water-soluble components contained in ambient PM can more readily permeate the alveolar-capillary barrier and gain access to the endothelial cells. Our study shows that PM can directly induce the production of H2O2 from NAD(P)H oxidase and the mitochondrial electron transport chain in vascular endothelial cells and that H2O2 produced from NAD(P)H oxidase mediates the PM-induced vasoconstriction. These results provided further evidence that PM may be an important risk factor for the development of cardiovascular diseases.
| GRANTS |
|---|
|
|
|---|
| DISCLOSURES |
|---|
| ACKNOWLEDGMENTS |
|---|
A portion of the study was presented in the Annual Meeting of the Society of Free Radical Biology Medicine in St. Thomas, Virgin Islands (Free Rad Biol Med 37, Suppl 1: S142, 2004).
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Bai Y, Suzuki AK, and Sagai M. The cytotoxic effects of diesel exhaust particles on human pulmonary artery endothelial cells in vitro: role of active oxygen species. Free Radic Biol Med 30: 555562, 2001.[CrossRef][ISI][Medline]
3. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, and Ping P. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res 90: 390397, 2002.
4. Batalha JR, Saldiva PH, Clarke RW, Coull BA, Stearns RC, Lawrence J, Murthy GG, Koutrakis P, and Godleski JJ. Concentrated ambient air particles induce vasoconstriction of small pulmonary arteries in rats. Environ Health Perspect 110: 11911197, 2002.[ISI][Medline]
5. Bateson TF and Schwartz J. Who is sensitive to the effects of particulate air pollution on mortality? A case-crossover analysis of effect modifiers. Epidemiology 15: 143149, 2004.[CrossRef][ISI][Medline]
6. Becker S, Dailey LA, Soukup JM, Grambow SC, Devlin RB, and Huang YCT. Seasonal variations in air pollution particle-induced inflammatory mediator release and oxidative stress. Environ Health Perspect 113: 10321038, 2005.[ISI][Medline]
7. Blanchet S, Ramgolam K, Baulig A, Marano F, and Baeza-Squiban A. Fine particulate matter induces amphiregulin secretion by bronchial epithelial cells. Am J Respir Cell Mol Biol 30: 421427, 2004.
8. Bouthillier L, Vincent R, Goegan P, Adamson IY, Bjarnason S, Stewart M, Guenette J, Potvin M, and Kumarathasan P. Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am J Pathol 153: 18731884, 1998.
9. Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, and Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 105: 15341536, 2002.
10. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC Jr, and Tager I. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 109: 26552671, 2004.[CrossRef][ISI][Medline]
11. Cai H and Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840844, 2000.
12. Chang J, Rao NV, Markewitz BA, Hoidal JR, and Michael JR. Nitric oxide donor prevents hydrogen peroxide-mediated endothelial cell injury. Am J Physiol Lung Cell Mol Physiol 270: L931L940, 1996.
13. Chen LC and Nadziejko C. Effects of subchronic exposures to concentrated ambient particles (CAPs) in mice. V. CAPs exacerbate aortic plaque development in hyperlipidemic mice. Inhal Toxicol 17: 217224, 2005.[CrossRef][ISI][Medline]
14. Dandrea T, Hellmold H, Jonsson C, Zhivotovsky B, Hofer T, Warngard L, and Cotgreave I. The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: relationship to DNA damage, cell cycle arrest, and caspase activation. Free Radic Biol Med 36: 881896, 2004.[CrossRef][ISI][Medline]
15. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, and Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 82: 10941101, 1998.
16. Dominici F, McDermott A, and Daniels D. Mortality among residents of 90 cities. In: Special Report: Revised Analyses of Time-Series Studies of Air Pollution and Health. Boston, MA: Health Effects Institute, 2003, p. 924.
17. Donaldson K, Stone V, Borm PJ, Jimenez LA, Gilmour PS, Schins RP, Knaapen AM, Rahman I, Faux SP, Brown DM, and MacNee W. Oxidative stress and calcium signaling in the adverse effects of environmental particles (PM10). Free Radic Biol Med 34: 13691382, 2003.[CrossRef][ISI][Medline]
18. Donaldson K, Stone V, Seaton A, and MacNee W. Ambient particle inhalation and the cardiovascular system: potential mechanisms. Environ Health Perspect 109, Suppl 4: 523527, 2001.[ISI][Medline]
19. Goldberg MS, Burnett RT, Bailar JC 3rd, Tamblyn R, Ernst P, Flegel K, Brook J, Bonvalot Y, Singh R, Valois MF, and Vincent R. Identification of persons with cardiorespiratory conditions who are at risk of dying from the acute effects of ambient air particles. Environ Health Perspect 109, Suppl 4: 487494, 2001.
20. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 11411148, 1994.[Abstract]
21. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494501, 2000.
22. Hauser R, Elreedy S, Hoppin JA, and Christiani DC. Airway obstruction in boilermakers exposed to fuel oil ash. A prospective investigation. Am J Respir Crit Care Med 152: 14781484, 1995.[Abstract]
23. Hiura TS, Kaszubowski MP, Li N, and Nel AE. Chemicals in diesel exhaust particles generate reactive oxygen radicals and induce apoptosis in macrophages. J Immunol 163: 55825591, 1999.
24. Holland JA, Meyer JW, Chang MM, O'Donnell RW, Johnson DK, and Ziegler LM. Thrombin stimulated reactive oxygen species production in cultured human endothelial cells. Endothelium 6: 113121, 1998.[ISI][Medline]
25. Huang YC, Wu W, Ghio AJ, Carter JD, Silbajoris R, Devlin RB, and Samet JM. Activation of EGF receptors mediates pulmonary vasoconstriction induced by residual oil fly ash. Exp Lung Res 28: 1938, 2002.[CrossRef][ISI][Medline]
26. Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, and Peters A. Effects of air pollution on blood pressure: a population-based approach. Am J Public Health 91: 571577, 2001.[Abstract]
27. Ikeda M, Suzuki M, Watarai K, Sagai M, and Tomita T. Impairment of endothelium-dependent relaxation by diesel exhaust particles in rat thoracic aorta. Jpn J Pharmacol 68: 183189, 1995.[Medline]
28. Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, and Matsumoto T. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 92: 8187, 2003.
29. Kan H, Jia J, and Chen B. The association of daily diabetes mortality and outdoor air pollution in Shanghai, China. J Environ Health 67: 2126, 2004.[ISI][Medline]
30. Kong JY, Klassen SS, and Rabkin SW. Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis. Mol Cell Biochem 278: 3951, 2005.[CrossRef][ISI][Medline]
31. Li Z, Carter JD, Dailey LA, and Huang YC. Vanadyl sulfate inhibits NO production via threonine phosphorylation of eNOS. Environ Health Perspect 112: 201206, 2004.[ISI][Medline]
32. Li Z, Carter JD, Dailey LA, and Huang YC. Pollutant particles produce vasoconstriction and enhance MAPK signaling via angiotensin type I receptor. Environ Health Perspect 113: 10091014, 2005.[ISI][Medline]
33. Mann JK, Tager IB, Lurmann F, Segal M, Quesenberry CP Jr, Lugg MM, Shan J, and Van Den Eeden SK. Air pollution and hospital admissions for ischemic heart disease in persons with congestive heart failure or arrhythmia. Environ Health Perspect 110: 12471252, 2002.[ISI][Medline]
34. Marumo T, Schini-Kerth VB, Fisslthaler B, and Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96: 23612367, 1997.[ISI][Medline]
35. O'Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA, Horton ES, and Schwartz J. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation 111: 29132920, 2005.
36. Park SK, O'Neill MS, Vokonas PS, Sparrow D, and Schwartz J. Effects of air pollution on heart rate variability: the VA normative aging study. Environ Health Perspect 113: 304309, 2005.[ISI][Medline]
37. Peters A, Dockery DW, Muller JE, and Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 103: 28102815, 2001.[ISI][Medline]
38. Pope CA, III. Respiratory hospital admissions associated with PM10 pollution in Utah, Salt Lake, and Cache Valleys. Arch Environ Health 46: 9097, 1991.[ISI][Medline]
39. Pope CA III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, and Godleski JJ. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109: 7177, 2004.[ISI][Medline]
40. Pope CA III, Schwartz J, and Ransom MR. Daily mortality and PM10 pollution in Utah Valley. Arch Environ Health 47: 211217, 1992.[ISI][Medline]
41. Poss WB, Timmons OD, Farrukh IS, Hoidal JR, and Michael JR. Inhaled nitric oxide prevents the increase in pulmonary vascular permeability caused by hydrogen peroxide. J Appl Physiol 79: 886891, 1995.
42. Suwa T, Hogg JC, Quinlan KB, Ohgami A, Vincent R, and van Eeden SF. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 39: 935942, 2002.
43. Therade-Matharan S, Laemmel E, Duranteau J, and Vicaut E. Reoxygenation after hypoxia and glucose depletion causes reactive oxygen species production by mitochondria in HUVEC. Am J Physiol Regul Integr Comp Physiol 287: R1037R1043, 2004.
44. Thomson E, Goegan P, Kumarathasan P, and Vincent R. Air pollutants increase gene expression of the vasoconstrictor endothelin-1 in the lungs. Biochim Biophys Acta 1689: 7582, 2004.[Medline]
45. Tzeng HP, Yang RS, Ueng TH, Lin-Shiau SY, and Liu SH. Motorcycle exhaust particulates enhance vasoconstriction in organ culture of rat aortas and involve reactive oxygen species. Toxicol Sci 75: 6673, 2003.
46. Vincent R, Kumarathasan P, Goegan P, Bjarnason SG, Guenette J, Berube D, Adamson IY, Desjardins S, Burnett RT, Miller FJ, and Battistini B. Inhalation toxicology of urban ambient particulate matter: acute cardiovascular effects in rats. Res Rep Health Eff Inst: 554; discussion 5562, 2001.
47. Woodin MA, Liu Y, Hauser R, Smith TJ, and Christiani DC. Pulmonary function in workers exposed to low levels of fuel-oil ash. J Occup Environ Med 41: 973980, 1999.[ISI][Medline]
This article has been cited by other articles:
![]() |
M. Medhora, Y. Chen, S. Gruenloh, D. Harland, S. Bodiga, J. Zielonka, D. Gebremedhin, Y. Gao, J. R. Falck, S. Anjaiah, et al. 20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L902 - L911. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |